Press Releases

VALLOUREC
French limited liability company (société anonyme) with a Board of Directors
with share capital of € 4,767,162.72
Registered office: 12, rue de la Verrerie – 92190 Meudon, France
Registered on the Nanterre Trade and Companies Register under n° 552 142 200

VALLOUREC
Société anonyme à Conseil d’Administration
au capital de 4 767 162,72 €
Siège social : 12, rue de la Verrerie – 92190 Meudon
552 142 200 RCS Nanterre

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET

Gereglementeerde informatie
Nazareth (België)/Rotterdam (Nederland), 18 juli 2025 – 18 CET

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

GRIMSBY, Ontario, July 18, 2025 (GLOBE NEWSWIRE) -- Andrew Peller Limited (ADW.A / ADW.B) will issue its financial results for the three months ended June 30, 2025, after close of market on Wednesday, August 6, 2025. Management will host a conference call to discuss the financial results on Thursday, August 7, 2025, at 10:00 a.m. (ET), followed by a question-and-answer period.

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter 

Explore the burgeoning world of Photonic Quantum Computers: these cost-effective, room-temperature machines promise significant growth, with revenues projected to soar from $1.1 billion in 2030 to $6.8 billion by 2035. Get insights on key players like PsiQuantum and market forecasts, covering vendors and components in a booming industry.